Literature DB >> 21849843

Angiopoietins as prognostic biomarkers and effector molecules in severe sepsis.

Enitan D Carrol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21849843      PMCID： PMC3160496          DOI： 10.1097/CCM.0b013e31821f02bf

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  2 in total

1.  Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis.

Authors:  Daniel R Ricciuto; Claudia C dos Santos; Michael Hawkes; Lisa J Toltl; Andrea L Conroy; Nimerta Rajwans; Erin I Lafferty; Deborah J Cook; Alison Fox-Robichaud; Kamyar Kahnamoui; Kevin C Kain; Patricia C Liaw; W Conrad Liles
Journal:  Crit Care Med       Date:  2011-04       Impact factor: 7.598

2.  The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children.

Authors:  Limangeni A Mankhambo; Daniel L Banda; Graham Jeffers; Sarah A White; Paul Balmer; Standwell Nkhoma; Happy Phiri; Elizabeth M Molyneux; C Anthony Hart; Malcolm E Molyneux; Robert S Heyderman; Enitan D Carrol
Journal:  Crit Care       Date:  2010-05-21       Impact factor: 9.097
  2 in total
  2 in total

Review 1.  Vascular dysfunction as a target for adjuvant therapy in cerebral malaria.

Authors:  Leonardo José de Moura Carvalho; Aline da Silva Moreira; Cláudio Tadeu Daniel-Ribeiro; Yuri Chaves Martins
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-08       Impact factor: 2.743

2.  A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia.

Authors:  Maiara Marx Luz Fiusa; Carolina Costa-Lima; Gleice Regina de Souza; Afonso Celso Vigorito; Francisco Jose Penteado Aranha; Irene Lorand-Metze; Joyce M Annichino-Bizzacchi; Carmino Antonio de Souza; Erich V De Paula
Journal:  Crit Care       Date:  2013-08-05       Impact factor: 9.097
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.